Form 4: Drugs Made In America Acquisition LLC Acquires 30,000 Units in DMAA

Drugs Made In America Acquisition LLC, a 10% owner and director, acquired 30,000 private units of Drugs Made In America Acquisition Corp. at $10 per unit on February 18, 2025.

Summary

• On February 18, 2025, Drugs Made In America Acquisition LLC acquired 30,000 private units of Drugs Made In America Acquisition Corp.
• The purchase price was $10 per unit, totaling $300,000.
• Each unit consists of one ordinary share and one right to receive one-eighth of an ordinary share upon the consummation of an initial business combination.
• Following the transaction, the reporting person beneficially owns 4,188,780 ordinary shares.
• The rights convert automatically into ordinary shares upon completion of the Issuer's initial business combination.

Sentiment

Score: 7

Explanation: The transaction is a routine purchase of units by the sponsor, indicating continued support and confidence in the company's prospects. It's a moderately positive signal.

Positives

• The acquisition demonstrates confidence in Drugs Made In America Acquisition Corp.'s future prospects.
• The purchase of units at $10 per unit provides additional capital to the company.
• The acquisition increases the reporting person's stake in the company.

Future Outlook

The rights to receive ordinary shares will convert automatically upon the completion of the Issuer's initial business combination.

Industry Context

This transaction is typical for special purpose acquisition companies (SPACs), where sponsors invest in units prior to the initial business combination.

Related Party Transactions

• The purchase of private units by Drugs Made In America Acquisition LLC, the Issuer's sponsor, is a related party transaction.

Stakeholder Impact

• The transaction signals confidence to shareholders.
• The capital injection from the unit purchase strengthens the company's financial position.

Next Steps

• The rights will convert to ordinary shares upon the completion of the initial business combination.

Key Dates

Keywords

Drugs Made In America Acquisition Corp, DMAA, Drugs Made In America Acquisition LLC, private units, ordinary shares, beneficial ownership, initial business combination, acquisition